|
7831 |
Tagungsbericht – Grundlagen und Grenzen einer Nutzung der Wirkprinzipien der Placeboeffekte in der medizinischen Behandlung, 20.10.2017, Berlin
Enthalten in Medizinrecht Bd. 36, 3.4.2018, Nr. 4, date:4.2018: 231-233
|
|
|
|
7832 |
Takhzyro® — erster Antikörper zur Prophylaxe des hereditären Angioödems
Enthalten in Gastronews Bd. 6, 5.8.2019, Nr. 4, date:8.2019: 52
|
|
|
|
7833 |
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial
Enthalten in Trials Bd. 20, 21.11.2019, Nr. 1, date:12.2019: 1-14
|
|
|
|
7834 |
TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease
Enthalten in Nature aging Bd. 3, 27.11.2023, Nr. 12, date:12.2023: 1591-1601
|
|
|
|
7835 |
Tapping-in Method (Skin Penetration Technique) with a Placebo Needle for Double-blind Acupuncture Trials
Enthalten in Deutsche Zeitschrift für Akupunktur Bd. 56, 1.7.2013, Nr. 3, date:7.2013: 25-26
|
|
|
|
7836 |
Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
Enthalten in Trials Bd. 14, 29.10.2013, Nr. 1, date:12.2013: 1-5
|
|
|
|
7837 |
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
Enthalten in Nature medicine Bd. 29, 24.4.2023, Nr. 6, date:6.2023: 1437-1447
|
|
|
|
7838 |
Taurine supplementation in children with autism spectrum disorders: a study protocol for an exploratory randomized, double-blind, placebo-controlled trial
Enthalten in BMC pediatrics Bd. 25, 27.10.2025, Nr. 1, date:12.2025: 1-12
|
|
|
|
7839 |
tDCS ist effektiv, aber SSRI unterlegen
Enthalten in Info Neurologie & Psychiatrie Bd. 19, 23.10.2017, Nr. 10, date:10.2017: 24-25
|
|
|
|
7840 |
Telemedizinische Palliativbetreuung bei ambulanten neurologischen Patienten
Enthalten in Schmerzmedizin Bd. 37, 28.5.2021, Nr. 3, date:5.2021: 7
|
|
Administration
